Aspirin Responsiveness in Women With Coronary Artery Disease
This study is currently recruiting participants.
Verified January 2012 by Creighton University
Sponsor:
Creighton University
Information provided by (Responsible Party):
Creighton University
ClinicalTrials.gov Identifier:
NCT01406990
First received: July 13, 2011
Last updated: January 16, 2012
Last verified: January 2012
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date ICMJE | July 13, 2011 | ||||
Last Updated Date | January 16, 2012 | ||||
Start Date ICMJE | June 2011 | ||||
Estimated Primary Completion Date | June 2013 (final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures ICMJE |
women with known CAD who are hyporesponsive to low dose (81mg) aspirin [ Time Frame: 1 year ] [ Designated as safety issue: No ] | ||||
Original Primary Outcome Measures ICMJE | Same as current | ||||
Change History | Complete list of historical versions of study NCT01406990 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures ICMJE | |||||
Original Secondary Outcome Measures ICMJE | |||||
Current Other Outcome Measures ICMJE | |||||
Original Other Outcome Measures ICMJE | |||||
Descriptive Information | |||||
Brief Title ICMJE | Aspirin Responsiveness in Women With Coronary Artery Disease | ||||
Official Title ICMJE | Aspirin Responsiveness in Women With Coronary Artery Disease | ||||
Brief Summary | The purpose of this study is to measure the percentage of women with known Coronary Artery Disease (CAD) who are hyporesponsive to low dose (81mg) aspirin. |
||||
Detailed Description | |||||
Study Type ICMJE | Observational | ||||
Study Design ICMJE | Observational Model: Cohort Time Perspective: Prospective |
||||
Biospecimen | |||||
Sampling Method | Non-Probability Sample | ||||
Study Population | Women between 45 and 85 years of age with known CAD on low dose Aspirin (81 mg) seen at the Cardiac Center of Creighton University |
||||
Condition ICMJE | CAD | ||||
Intervention ICMJE | |||||
Study Group/Cohort (s) | low dose Aspirin | ||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status ICMJE | Recruiting | ||||
Estimated Enrollment ICMJE | 75 | ||||
Estimated Completion Date | June 2013 | ||||
Estimated Primary Completion Date | June 2013 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
Gender | Female | ||||
Ages | 45 Years to 85 Years | ||||
Accepts Healthy Volunteers | No | ||||
Contacts ICMJE |
|
||||
Location Countries ICMJE | United States | ||||
Administrative Information | |||||
NCT Number ICMJE | NCT01406990 | ||||
Other Study ID Numbers ICMJE | 11-16154 | ||||
Has Data Monitoring Committee | No | ||||
Responsible Party | Creighton University | ||||
Study Sponsor ICMJE | Creighton University | ||||
Collaborators ICMJE | |||||
Investigators ICMJE |
|
||||
Information Provided By | Creighton University | ||||
Verification Date | January 2012 | ||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |